Please assess the completion status of the following clinical trial:

Trial Title: Oral Nifedipine Versus Oral Labetalol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years with the abililty to give informed consent~* Intrauterine pregnancy ≥ 32 weeks~* Postpartum~* Persistent postpartum blood pressures ≥ 160/105 on two or more occasions~* Primary obstetrician amenable to starting either study medication in the postpartum period~Exclusion Criteria:~* Use of other oral antihypertensives concomitantly~* Known AV heart block~* HR \<60 or \>120~* Absolute contraindication to nifedipine or labetolol such as allergy~* Significant renal disease (Cr \>1.5 mg/dL)~* Heart failure~* Moderate persistent or severe asthma~* Preexisting diagnosis of chronic hypertension with medical treatment before delivery~* Chronic hypertension

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Labetalol (Type: OTHER): Labetalol 200mg PO BID starting dose
- Nifedipine (Type: OTHER): Nifedpine XL starting at dose 30mg PO daily

Based on this trial design, predict the completion outcome and termination type (if applicable).